Rufinamide/Felbamate/Lacosamide Serum Control, Bi-Level (I+II)

Order No.: 0065
Eslicarbazepine, Felbamate, Lacosamide, N-Desmethylmesuximide, Rufinamide

 0065 Rufinamide, Felbamate, Lacosamide Serum Control, Bi-Level I + II (lyoph.)
(Rufinamide, Felbamate, Lacosamide, Eslicarbazepine, N-Desmethylmesuximide), 2 x 5 x 2 ml

These lyophilised quality controls from Chromsystems are based on human serum and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of rufinamide, felbamate, lacosamide in serum/plasma. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.

More Information
Content 2 x 5 x 2 ml (lyoph.)

Please note: Concentration values shown here are typical. For lot specific concentration values please refer to the product insert supplied with the materials. The product inserts can also be requested from us directly or downloaded from our website after login.

SubstanceValue Level IRange Level IValue Level IIRange Level II
Lacosamide 7.62 mg/l 6.10-9.14 mg/l 16.9 mg/l 13.5-20.3 mg/l
Felbamate 36.5 mg/l 29.2-43.8 mg/l 87.0 mg/l 69.6-104 mg/l
Rufinamide 16.4 mg/l 13.1-19.7 mg/l 39.3 mg/l 31.4-47.2 mg/l
Eslicarbazepine 7.78 mg/l 6.22-9.34 mg/l 17.4 mg/l 13.9-20.9 mg/l
N-Desmethylmesuximide 18.3 mg/l 14.6-22.0 mg/l 35.7 mg/l 28.6-42.8 mg/l
Storage conditions

Stored below -18 °C and unopened, the lyophilised controls are stable until the expiry date specified on the vial labels. The reconstituted controls can be stored up to 3 days tightly capped at +2 to +8 C. If the controls cannot be used within this period, they should be aliquoted and stored frozen below -18 °C (up to 3 months). For more details about storage conditions please check your instruction manual.

Method of Analysis HPLC
Parameter Eslicarbazepine, Felbamate, Lacosamide, N-Desmethylmesuximide, Rufinamide
As a customer please login or register to gain full access.